Загрузка...
Statistical considerations for pediatric multidrug–resistant tuberculosis efficacy trials
Inclusion of newly licensed or repurposed drugs in regimens to treat children for multidrug–resistant–tuberculosis may lead to therapy that is shorter than traditional regimens and composed only of oral medications. As an all–oral regimen may be more acceptable and have a better safety profile than...
Сохранить в:
| Опубликовано в: : | Int J Tuberc Lung Dis |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6086568/ https://ncbi.nlm.nih.gov/pubmed/29665951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0358 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|